Navigation Links
Tiens Biotech Group (USA) Reports 2010 Results
Date:3/31/2011

RIBUTABLETO THE NONCONTROLLING INTEREST664,854993,504COMPREHENSIVE INCOME

$

10,631,972

$

19,245,909EARNINGS PER SHARE, BASIC AND DILUTED

$

0.07

$

0.33WEIGHTED AVERAGE NUMBER OF SHARES, BASIC AND DILUTED71,333,58671,333,586The accompanying notes are an integral part of this statement.TIENS BIOTECH GROUP (USA), INC. AND SUBSIDIARIESCONSOLIDATED BALANCE SHEETSAS OF DECEMBER 31, 2010 AND DECEMBER 31, 2009December 31,December 31,20102009A S S E T SCURRENT ASSETS:Cash

$

10,155,522

$

1,848,328Accounts receivable, trade - related parties, net of allowance for doubtful accounts of $3,869,617 and $1,419,178 as of December 31, 2010 and December 31, 2009 , respectively10,012,86115,379,312Inventories5,703,3495,328,052Other receivables1,045,952995,657Other receivables - related parties17,376,52244,561,626Employee advances170,842115,673Prepaid expenses, net415,208658,193Prepaid taxes3,646,140407,534Total current assets48,526,39669,294,375PROPERTY, PLANT AND EQUIPMENT, net72,037,54210,124,483OTHER ASSETS:Construction in progress128,715,283125,572,621Construction deposits12,490,8551,405,997Intangible assets, net12,987,00012,864,295Other assets10,721,04011,847,937Total other assets164,914,178151,690,850Total assets

$

285,478,116

$

231,109,708L I A B I L I T I E S
A N D
S H A R E H O L D E R S'   E Q U I T YCURRENT LIABILITIES:Accounts payable

$

14,120,791

$

5,012,157Advances from customers - related parties8,688,8774,426,751Wages and benefits payable1,613,7821,484,852Short-term debt3,024,800-Income taxes payable490,782-Contractor deposits209,376183,395Contractor payables28,134,71118,513,216Other payables 1,113,4161,151,551Other payables - related parties1,417,5163,326,110Total current liabilities58,814,05134,098,032NON-CURRENT LIABILITIESLong term debt18,451,280-Deferred income11,473,85311,236,501Total non current liabilities29,925,133
'/>"/>

SOURCE Tiens Biotech Group (USA), Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
2. Tiens Biotech Group (USA) Reports First Quarter Results
3. Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
4. Tiens Biotech Group (USA) Reports First Quarter Results
5. Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
6. Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results
7. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
8. Yongye Biotechnology International Retains CCG Investor Relations
9. ThirdBiotech Announces Kemeta as Newest Sponsor
10. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
11. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Docetaxel Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... and NEW YORK , ... PTBI, PTBIW), a biopharmaceutical company advancing patient care in ... offering of 3,500,000 shares of common stock, and warrants ... common stock, at an offering price of $4.00 per ... per share exercise price of $5.00, are exercisable immediately, ...
(Date:12/24/2014)... Earlier this year in a June 24 international ... Adult Stem Cell Technology Center, LLC ( ASCTC ) ... unique property of adult tissue stem cells. His ... the Past, Important for the Future,” embodied the essence ... the address at the 4th World Congress on Cell ...
(Date:12/24/2014)... Nashville Fertility Center announced that Dr. George ... Society for Reproductive Medicine (ASRM), a leading professional organization ... In his new role as treasurer, Dr. Hill ... will have a voice in furthering the mission of ... since 1984 when he joined while conducting fellowship training ...
(Date:12/24/2014)... PharmaBoardroom,s new report, , Healthcare and ... free download , digs deep into this vibrant market, ... sector today. One area where Algeria ... a homegrown pharmaceutical manufacturing base, even if the government,s ambitious ... off. A cursory comparison with neighboring Morocco ...
Breaking Biology Technology:PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3
... REDWOOD CITY, Calif., March 4 Maxygen, Inc.,(Nasdaq: ... the development of,improved protein drugs, today announced changes ... president in charge of global,business development and U.S. ... business officer. In addition, the company announced the,pending ...
... FRANCISCO, Calif., March 4 Sunesis,Pharmaceuticals, Inc. (Nasdaq: ... anticancer therapeutics, will present data at the,upcoming 39th ... Society of,Gynecologic Oncologists (SGO). This year,s conference will ... Center in Tampa, Fla., Interim data from ...
... Set to Dramatically Improve Airway Inflammatory Disease ... Personalized Inflammation Control, NEW PROVIDENCE, N.J., March 4 ... MINO (http://www.nioxmino.com ), a,hand- held point-of-care device for ... the U.S. Food and Drug Administration (FDA).,Physicians in the ...
Cached Biology Technology:Maxygen Announces Management Changes 2Sunesis Pharmaceuticals to Present Interim Phase 2 Data for SNS-595 at the 39th Annual Meeting on Women's Cancer 2FDA Grants Market Clearance to Aerocrine Inc.'s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma 2FDA Grants Market Clearance to Aerocrine Inc.'s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma 3FDA Grants Market Clearance to Aerocrine Inc.'s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma 4
(Date:12/22/2014)... DUBLIN , Dec. 22, 2014 /PRNewswire/ ... ) has announced the addition of the ... report to their offering. ... This insight provides an overview of the ... Watermarking aims to control and monitor piracy ...
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , ... for the post-password and Internet of Things era, today ... funding. The venture round was led by Metamorphic Ventures ... Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey has raised ... funding to expand its team and bring LaunchKey to ...
(Date:12/17/2014)... 16, 2014 Research and Markets ... the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major trend ... for medical sensors in biomedical applications. Chemical sensors ... and correct diagnosis during surgical procedures. The Global ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
... the only ones who have taken to setting up home ... this week in the Proceedings of the National Academy ... populations in a network of marine protected areas information ... does for the first time is to demonstrate that a ...
... Certain bacteria have learned to manipulate the proportion of ... researchers have mapped the entire genome of a bacterium ... The findings, published in PNAS, reveal extremely high frequencies ... the future it is hoped that it will be ...
... literature on transient receptor potential (TRP) channelsion channels ... touch, olfaction, and other sensesvery little is known ... mechanisms that control their gating processes. , In ... http://jgp.rupress.org/current.shtml ), the Journal of General Physiology ...
Cached Biology News:You don't call, you don't write: Connectivity in marine fish populations 2You don't call, you don't write: Connectivity in marine fish populations 3Gene exchange common among sex-manipulating bacteria 2
... years of expertise in the field of ... the most powerful systems on the market. ... 000 in-microplate tests requiring incubation and washing ... modules (such as worktable shaker incubators, reader,washer), ...
... pre-validated SNP sequencing services ... within 93 genes including ... more than 80 tyrosine ... were developed and validated ...
... Mouse anti-Yersinia pestis F1 antigen, ... Applications: ELISA: Use at ... at an assay dependent dilution. WB: ... Predicted molecular weight: 18 kDa. Not ...
... Fixation medium Reagent B - Permeabilisation medium ... cells in suspension with Reagent A and ... This procedure gives antibodies access to intracellular ... of the cells intact. Specific formulations reduce ...
Biology Products: